Blog
RSS FeedPosted by Michael Wonder on 14 Dec 2017
Bumper crop of new drugs fails to lift big pharma R&D returns
14 December 2017 - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice ...
Posted by Michael Wonder on 08 Dec 2017
Remarks from FDA Commissioner as prepared for oral testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions Hearing, “Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation
7 December 2017 - FDA Commissioner Gottlieb provides testimony before the U.S. Senate HELP Committee on the agency’s implementation of the ...
Posted by Michael Wonder on 08 Dec 2017
Statement from FDA Commissioner on advancing new digital health policies to encourage innovation, bring efficiency and modernisation to regulation
7 December 2017 - Today we’re announcing three new, significant policy documents to advance the FDA’s approach to the development ...
Posted by Michael Wonder on 04 Dec 2017
Brand name drug sales soar in Canada, while R&D sags
1 December 2017 - Patented drug industry disputes it's failing to invest enough into research and development. ...
Posted by Michael Wonder on 03 Dec 2017
Access to new medicines in New Zealand - 2017 in review
3 December 2017 - As 2017 draws to a close and the year's last update of the New Zealand Pharmaceutical ...
Posted by Michael Wonder on 02 Dec 2017
Accelerated access to new drugs and technologies
22 November 2017 - UK government’s proposed scheme is unlikely to improve patient outcomes. ...
Posted by Michael Wonder on 31 Oct 2017
Fund for next generation medicines investigated
1 November 2017 - A fund to give Kiwis quicker access to new-generation medicines will be investigated by the Government, ...
Posted by Michael Wonder on 30 Oct 2017
The innovation health care really needs: help people manage their own health
30 October 2017 - Finally, health care, which has been largely immune to the forces of disruptive innovation, is beginning ...
Posted by Michael Wonder on 24 Oct 2017
Medical device development tools: helping to speed medical device evaluation and approval
24 October 2017 - The FDA relies on sound science in its decision-making, which provides medical device innovators with a ...
Posted by Michael Wonder on 24 Oct 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance medical device innovation and help patients gain faster access to beneficial technologies
24 October 2017 - Enabling patients and providers to have efficient access to new and innovative medical products that meet ...
Posted by Michael Wonder on 20 Oct 2017
New action plan to foster development of advanced therapies
20 October 2017 - Actions address specific challenges identified by stakeholders. ...
Posted by Michael Wonder on 14 Oct 2017
Nearly one-third of new drugs are no better than older drugs, and some are worse
6 October 2017 - A focus on expediting drug development. ...
Posted by Michael Wonder on 10 Oct 2017
Can the U.S. repair its health care while keeping its innovation edge?
9 October 2017 - The United States health care system has many problems, but it also promotes more innovation than ...
Posted by Michael Wonder on 12 Sep 2017
Why is the FDA chief so worried about pharma profits?
11 September 2017 - Developing new drugs is a costly business. So, too, is paying for the ever more expensive ...
Posted by Michael Wonder on 24 Aug 2017
PCSK9 inhibitors and the choice between innovation, efficiency, and affordability
22 August 2017 - Cardiovascular medicine is struggling with the new proprotein convertase subtilisin/kexin type 9 inhibitor drugs for lowering low-density ...